menu
Create
Copyright © 2024 Digital media blog website. All rights reserved.
havensmith
havensmith
havensmith
Follow
Total News
203
Total Lists
0
Total Videos
0
joined at 3 years ago

    The PROs Further Support Durvalumab + Chemo in Becoming...

    The PROs Further Support Durvalumab + Chemo in Becoming The New Standard of...

    • havensmith

    ASCO Conference Analysis- Oncological Abstracts Data

    ASCO Conference Analysis- Oncological Abstracts Data

    • havensmith

    Takeda’s Flagship Product Panitumumab (PAN)+mFOLFOX6 Ve...

    Takeda’s Flagship Product Panitumumab (PAN)+mFOLFOX6 Versus bevacizumab (BE...

    • havensmith

    ASCO Conference Highlights: Metastatic Colorectal Cance...

    ASCO Conference Highlights: Metastatic Colorectal Cancer, Bladder Cancer

    • havensmith

    Making Way For Immunotherapy In The GI Cancers, Durvalu...

    Making Way For Immunotherapy In The GI Cancers, Durvalumab To Become The Ne...

    • havensmith

    Chronic Obstructive Pulmonary Disease Market Insight, E...

    Chronic Obstructive Pulmonary Disease Market Insight, Epidemiology And Mark...

    • havensmith

    ASCO Conference Abstracts - Major Data Readouts

    ASCO Conference Abstracts - Major Data Readouts

    • havensmith

    With modest efficacy, Neratinib Continues To Be A Poten...

    With modest efficacy, Neratinib Continues To Be A Potential Treatment Optio...

    • havensmith

    Chronic Lower Back Pain Market Insight, Epidemiology An...

    Chronic Lower Back Pain Market Insight, Epidemiology And Market Forecast 20...

    • havensmith

    Is there enough opportunity in the competitive therapeu...

    Is there enough opportunity in the competitive therapeutic landscape of Mul...

    • havensmith

    Daiichi’s novel HER3 ADC has Shown To Have a Spark in H...

    Daiichi’s novel HER3 ADC has Shown To Have a Spark in HER3 NSCLC, post succ...

    • havensmith

    Treatment resistant depression Market Insight, Epidemio...

    Treatment resistant depression Market Insight, Epidemiology And Market Fore...

    • havensmith

    Junshi’s domestic Toripalimab’s significant results in...

    Junshi’s domestic Toripalimab’s significant results in recurrent or metasta...

    • havensmith

    Sermonix’s Lasofoxifene, a potent oral SERM, emerges as...

    Sermonix’s Lasofoxifene, a potent oral SERM, emerges as a critical player i...

    • havensmith

    Nasal Polyposis Market Insight, Epidemiology And Market...

    Nasal Polyposis Market Insight, Epidemiology And Market Forecast 2032

    • havensmith